Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy

BACKGROUND/OBJECTIVE: B3 breast lesions, of uncertain malignant potential, pose diagnostic challenges owing to their intermediate malignancy risk. While surgical excision (SE) is traditionally used for definitive diagnosis, vacuum-assisted excision (VAE) offers a less invasive alternative. As diagnostic practices evolve, this study assesses the financial impact of adopting VAE for B3 lesion management from the hospital perspective within the Italian healthcare system. MATERIALS AND METHODS: A budget impact analysis (BIA) was conducted from the hospital perspective over a 5-year time horizon. Clinical complication rates for SE and VAE were derived through a systematic literature review and meta-analysis. A micro-costing approach was used to estimate direct medical costs on the basis of detailed resource utilization data collected via structured questionnaires administered across five Italian hospitals. One-way sensitivity analyses and scenario analyses were conducted to test the robustness of the results. RESULTS: VAE was associated with significantly lower costs than SE, mainly owing to reduced hospitalization, operating room use, and personnel time. The average per-patient cost was €820 for VAE versus €1663 for SE, yielding savings of €843. Over 5 years, with VAE adoption rising from 20% to 80%, cumulative hospital savings were estimated to be between €11.1 million and €13.7 million. These findings were further confirmed by multiple budget impact scenario analyses, which consistently demonstrated a favorable economic profile for VAE across all tested assumptions. CONCLUSIONS: In our analysis, VAE represented a cost-saving, minimally invasive alternative to SE for the management of B3 breast lesions from the hospital perspective in Italy. Its adoption can enhance hospital efficiency and support more sustainable resource allocation within the Italian healthcare system.

Authors

Institutions

Publication Details

Journal
PharmacoEconomics - Open
Published
2026-06-09
DOI
https://doi.org/10.1007/s41669-026-00663-w
Primary Topic
Global Cancer Incidence and Screening
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy

Rosanna Tarricone, Salvatore Minelli, Secondo Folli, Carla Rognoni et al.
PharmacoEconomics - Open
Global Cancer Incidence and Screening
article

Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy

Rosanna Tarricone, Salvatore Minelli, Secondo Folli, Carla Rognoni, Valeria Romeo, Ludovico Cavallaro, Anna Russo, Nicola Rocco, Modestino Pezzella, Francesca Caumo, Catherine Depretto, Gaia Grassi, Gianfranco Scaperrotta
article en

Abstract

BACKGROUND/OBJECTIVE: B3 breast lesions, of uncertain malignant potential, pose diagnostic challenges owing to their intermediate malignancy risk. While surgical excision (SE) is traditionally used for definitive diagnosis, vacuum-assisted excision (VAE) offers a less invasive alternative. As diagnostic practices evolve, this study assesses the financial impact of adopting VAE for B3 lesion management from the hospital perspective within the Italian healthcare system. MATERIALS AND METHODS: A budget impact analysis (BIA) was conducted from the hospital perspective over a 5-year time horizon. Clinical complication rates for SE and VAE were derived through a systematic literature review and meta-analysis. A micro-costing approach was used to estimate direct medical costs on the basis of detailed resource utilization data collected via structured questionnaires administered across five Italian hospitals. One-way sensitivity analyses and scenario analyses were conducted to test the robustness of the results. RESULTS: VAE was associated with significantly lower costs than SE, mainly owing to reduced hospitalization, operating room use, and personnel time. The average per-patient cost was €820 for VAE versus €1663 for SE, yielding savings of €843. Over 5 years, with VAE adoption rising from 20% to 80%, cumulative hospital savings were estimated to be between €11.1 million and €13.7 million. These findings were further confirmed by multiple budget impact scenario analyses, which consistently demonstrated a favorable economic profile for VAE across all tested assumptions. CONCLUSIONS: In our analysis, VAE represented a cost-saving, minimally invasive alternative to SE for the management of B3 breast lesions from the hospital perspective in Italy. Its adoption can enhance hospital efficiency and support more sustainable resource allocation within the Italian healthcare system.

PharmacoEconomics - Open
Ospedale Antonio Cardarelli (IT), Ospedale Sacro Cuore Don Calabria (IT), Casa di Cura Villa Garda (IT), Istituto Oncologico Veneto (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Bocconi University (IT), University of Naples Federico II (IT)
Industry, innovation and infrastructure
Openalex Percentile: Top 8%
Global Cancer Incidence and Screening
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.